Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$60.14 - $75.36 $0 - $0
0 New
0 $0
Q4 2023

Feb 09, 2024

BUY
$42.85 - $69.5 $0 - $0
0 New
0 $0
Q3 2023

Nov 03, 2023

BUY
$49.5 - $66.6 $0 - $0
0 New
0 $0
Q2 2023

Aug 14, 2023

BUY
$48.54 - $61.64 $0 - $0
0 New
0 $0
Q1 2023

Jan 10, 2025

BUY
$46.12 - $65.71 $0 - $0
0 New
0 $0
Q1 2023

May 11, 2023

BUY
$46.12 - $65.71 $0 - $0
0 New
0 $0
Q4 2022

Jan 10, 2025

BUY
$45.51 - $65.08 $0 - $0
0 New
0 $0
Q4 2022

Feb 14, 2023

BUY
$45.51 - $65.08 $0 - $0
0 New
0 $0

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.31B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.